Market for Cozaar generics getting heated

With many global makers' blockbuster products coming off patent, the race for the generic drug market is set to be in full force in the fourth quarter of this year.

The drug recently at the center of attention is the best-selling Cozaar (losartan), an antihypertensive agent whose annual market is valued at 78 billion won.

Cozaar is in a class of drugs called angiotensin II receptor antago...